Minhee Kang, PhD

Senior Research Scientist
Harvard T.H. Chan School of Public Health
Boston, Massachusetts, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• LB749 - High HBsAb Seroprotection Achieved 4 Weeks after 3 doses of HepB-CpG Vaccine in People Living with HIV (PLWH) without Prior HBV Vaccination (ACTG A5379 Group B Preliminary Results)

  Thursday, October 20, 2022
  2:33 PM – 2:45 PM US ET